111
Views
2
CrossRef citations to date
0
Altmetric
Editorial

The pleomorphism of systemic sclerosis: are we ready for ‘personalized medicine’ in scleroderma?

Pages 403-405 | Published online: 10 Jan 2014

References

  • Ginsburg GS, Willard HF. Genomic and personalized medicine: foundations and applications. Transl. Res.154(6), 277–287 (2009).
  • Ellsworth RE, Decewicz DJ, Shriver CD, Ellsworth DL. Breast cancer in the personal genomics era. Curr. Genomics11(3), 146–161 (2010).
  • Scherer HU, Dorner T, Burmester GR. Patient-tailored therapy in rheumatoid arthritis: an editorial review. Curr. Opin. Rheumatol.22(3), 237–245 (2010).
  • Steen VD. Autoantibodies in systemic sclerosis. Semin. Arthritis Rheum.35(1), 35–42 (2005).
  • Arnett FC, Gourh P, Shete S et al. Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African–American and Hispanic cases and 1000 controls. Ann. Rheum. Dis.69(5), 822–827 (2010).
  • Agarwal SK. The genetics of systemic sclerosis. Discov. Med.10(51), 134–143 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.